
Originally created in March 1982 in response to the injury of Henry Stifel, the Christopher & Dana Reeve Foundation – first established as the Stifel Paralysis Research Foundation – is marking its 40th anniversary.
Over the last four decades, the Reeve Foundation has evolved to become a paralysis-focused non-profit organisation working across the United States and globally to address a dual care-cure mission – providing free, comprehensive resources to help those impacted by spinal cord injury (SCI) and paralysis as it advances the most promising scientific advances toward cures.
As the Foundation marks this milestone, it celebrates 40 years of progress and the seismic shift that it helped steer to move the field of SCI research to its current state, whereby scientists agree that paralysis cures are not a matter of ‘if’ but ‘when’.
The origins
Forty years ago, on March 12, Henry Stifel, then 17-years-old, was in a car accident that shattered his vertebrae, leaving him paralysed from the chest down.
When his parents, Hank and Charlotte Stifel, pressed doctors about what came next, the answers reflected the widespread belief that SCI was untreatable.
Christopher Reeve was already Superman, but the Reeve Foundation wouldn’t exist for another 14 years.
So, the Stifels decided to build their own, and the Stifel Paralysis Research Foundation launched later that year.
In the mid-1980s, Hank brought the Foundation under the umbrella of the American Paralysis Association (APA), where he helped establish an external scientific advisory council to review and advise its grant awards, funding research in a way that was completely novel to SCI – a “laboratory without walls.”
The scientific rigour helped expand the number of scientists and academics pursuing spinal cord research and encouraged the innovative work that would eventually upend the notion that there was nothing to be done for those living with paralysis.
When Christopher Reeve was injured in 1995, the APA was one of the first places that he and his wife Dana turned to for guidance.
The following year, he started the Christopher Reeve Foundation.
By 1999, the APA and Christopher’s Foundation came together as the Christopher Reeve Paralysis Foundation, which also added Dana’s name after her untimely death in March 2006.
Pushing the boundaries of what was accepted
The Reeve Foundation started as a grassroots movement by pioneers who refused to accept the long-standing belief that the spinal cord, once injured, could never be repaired.
Because of this view, SCI research was in its infancy in the 1980s and nicknamed the “graveyard of neurobiology”.
Today, however, the Foundation has funded more than $140million of research around the world.
By uniting the brightest minds in the field, the Foundation helped usher a new era of scientific inquiry focused on developing and delivering real-world treatments that would push the world toward real cures for SCI.
“The Reeve Foundation substantially changed perceptions about what was possible for spinal cord injury recovery and regeneration,” says Dr James D. Guest, professor at the Department of Neurological Surgery, The Miami Project to Cure Paralysis, and adviser to the Foundation.
“Through its support of cutting-edge basic SCI science and its role as a convener and credible arbiter of strong research, the field began to shift from an obscure specialty practiced by a handful of dedicated scientists in isolated labs to one of the most exciting and collaborative areas of neuroscience.”
Further, an important step was taken towards actual clinical implementation of discoveries through the establishment of the North American Clinical Trials Network (NACTN).
The network has enrolled more than 1,000 subjects to a data registry, and participated in the largest international clinical trial for SCI of the 21st Century, testing the drug riluzole.
NACTN actively collaborates with other clinical trial networks in Europe and Canada.
From ‘no hope’ to cures in sight
Building on a wealth of basic science discovery that had begun to unravel some of the most complex mechanisms of SCI and paralysis, in the mid-2000s, the Foundation zeroed in on an area of study with the potential to dramatically change what it means to live with paralysis: epidural stimulation, by which continuous electrical currents are applied at varying frequencies and intensities to specific locations on the spinal cord to

Maggie Goldberg, President and CEO
activate the nerve circuits and augment small residual signals from the brain.
Working with the earliest pioneers in this area, the Foundation launched The Big Idea with the University of Louisville in 2014 – a momentous step toward the expansion of its mission-driven outlook from just one cure to many, and a groundbreaking study that underscores the Foundation’s commitment to translating scientific results into tangible, quality of life gains for patients in the here and now.
The Big Idea is helping participants living with SCI dramatically improve their quality of life through improved cardiovascular health, bladder control, and other autonomic functions – and voluntary movement, including the previously impossible task of walking over ground.
Improved cardiovascular function is anticipated to be the first market indication pursued through the FDA for the technology, with data from the Big Idea supporting that application. To date, $9.4million funding for The Big Idea from the Reeve Foundation has been leveraged by the University of Louisville researchers to generate $31million in adjoining financial support for related research.
More recently, the Foundation has begun making forays into research-driven equity partnerships, such as with ONWARD, which has developed breakthrough technologies currently in global clinical trials that deliver individualised transcutaneous stimulation to the spinal cord in combination with intensive rehabilitation to improve arm and hand recovery (Up-LIFT study).
A second program uses targeted, programmed epidural stimulation of the spinal cord to restore movement and other functions. The results of the pioneering STIMO-BRIDGE Study, which highlights the use of ONWARD’s technology to enable people with even the most severe forms of spinal cord injury to walk, stand, cycle, and swim again, have shown what is possible.
In 2021, the Reeve Foundation created a strategic partnership with the UK’s International Spinal Research Trust (ISRT) to co-develop a research strategy with a joint focus on chronic injury, combination approaches and clinical translation.
This alliance, inspired by the speed at which solutions for COVID-19 have been delivered, seeks to take a coordinated, global approach to accelerate the processes of bringing meaningful treatments to those living with SCI.
“No other entity in SCI is engaged in the scientific pipeline at both the scientific and business support perspectives,” says Maggie Goldberg, president and CEO of the Reeve Foundation.
“While funding agencies support portions of the research continuum, they lack the ability to help advance research from the lab to bedside, and there is little critical assessment of product marketability.
“The Reeve Foundation is committed to filling these core gaps that have to date stymied the field.”
Support for people living with paralysis
In 2002, the Foundation’s National Paralysis Resource Center (NPRC) opened its doors with the leadership and vision of Dana Reeve, who, with Christopher, struggled to find resources to help their family build a new normal after his spinal cord injury.
Through the NPRC, the Reeve Foundation offers a free, comprehensive, national source of informational support for people living with paralysis – from SCI, multiple sclerosis, stroke, ALS, traumatic brain injury, and other causes – and their caregivers.
The NPRC is focused on helping clients overcome the day-to-day challenges of paralysis while trying to lead independent and fulfilling lives.
To date, the NPRC has served over 112,000 people across the US living with paralysis, their families, and caregivers with one-on-one assistance since its inception.
Visits to the Foundation’s website average three million per year and provide individuals with a wealth of information, including fact sheets, tool kits, a 400-page Paralysis Resource Guide and more, all translated into 12 additional languages.